TransMedics Group, Inc.
(NASDAQ : TMDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.45%458.961.0%$721.87m
ABTAbbott Laboratories 0.72%118.290.8%$614.91m
MDTMedtronic Plc 0.77%125.140.6%$528.59m
DHRDanaher Corp. 0.39%253.650.7%$510.15m
ISRGIntuitive Surgical, Inc. 1.56%833.382.3%$509.12m
BDXBecton, Dickinson & Co. -0.66%242.481.0%$368.51m
BSXBoston Scientific Corp. -0.17%41.541.0%$364.50m
ALGNAlign Technology, Inc. 2.79%569.046.3%$329.80m
DXCMDexCom, Inc. 2.87%333.257.8%$288.03m
SYKStryker Corp. 2.20%253.291.3%$274.34m
EWEdwards Lifesciences Corp. 1.82%89.540.4%$251.67m
BAXBaxter International, Inc. 0.50%83.821.8%$206.38m
AAgilent Technologies, Inc. 0.98%131.301.6%$196.63m
IDXXIDEXX Laboratories, Inc. 2.32%530.073.8%$189.57m
ZBHZimmer Biomet Holdings, Inc. 0.91%167.131.7%$174.37m

Company Profile

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.